O. Klungel

First name
O.
Middle name
H.
Last name
Klungel
van Dalem, J., Werkman, C., van den Bergh, J. P., Rossi, B., Viggers, R., Eastell, R., et al. (2022). "Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: a population-based cohort study". Diabetes Res Clin Pract, 109993. http://doi.org/10.1016/j.diabres.2022.109993
Leung, M. W., Bazelier, M. T., Souverein, P. C., Uitdehaag, B. M., Klungel, O. H., Leufkens, H. G., & Pajouheshnia, R. (2022). Mapping the risk of infections in patients with multiple sclerosis: A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum. Mult Scler, 13524585221094218. http://doi.org/10.1177/13524585221094218
van Veelen, A., Abtahi, S., Souverein, P., Driessen, J. H. M., Klungel, O. H., Dingemans, A. C., et al. (2022). Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors. Cancer Epidemiol, 78, 102149. http://doi.org/10.1016/j.canep.2022.102149
de Jong, H. J., Klungel, O. H., van Dijk, L., Vandebriel, R. J., Leufkens, H. G., van der Laan, J. W., et al. (2012). Use of statins is associated with an increased risk of rheumatoid arthritis. Ann Rheum Dis. http://doi.org/10.1136/ard.2011.155622
van den Ham, H. A., Klungel, O. H., Leufkens, H. G., & van Staa, T. P. (2013). The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation. J Thromb Haemost. http://doi.org/10.1111/jth.12041
Abbing-Karahagopian, V., Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G., Slattery, J., et al. (2014). Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-014-1676-z
Abbing-Karahagopian, V., Kurz, X., de Vries, F., van Staa, T. P., Alvarez, Y., Hesse, U., et al. (2014). Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol.
Fournier, J. P., Duijnhoven, R. G., Renoux, C., Dell'Aniello, S., Klungel, O. H., & Suissa, S. (2014). Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study. Menopause. http://doi.org/10.1097/gme.0000000000000279
Wing, K., Douglas, I., Bhaskaran, K., Klungel, O. H., Reynolds, R. F., Pirmohamed, M., et al. (2014). Development of predictive genetic tests for improving the safety of new medicines: the utilization of routinely collected electronic health records. Drug Discov Today. http://doi.org/10.1016/j.drudis.2013.11.003
van den Ham, H. A., Klungel, O. H., Singer, D. E., Leufkens, H. G., & van Staa, T. P. (2015). Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database. J Am Coll Cardiol. http://doi.org/10.1016/j.jacc.2015.08.033